Photodynamic therapy for subfoveal choroidal neovascularization.
D054598:Blue Cross Blue Shield Insurance Plans; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D018795:Device Approval; D017277:Drug Approval; D019317:Evidence-Based Medicine; D006801:Humans; D007834:Lasers; D008268:Macular Degeneration / Q000150:complications; D017063:Outcome Assessment, Health Care; D010778:Photochemotherapy / Q000379:methods; D017319:Photosensitizing Agents / Q000627:therapeutic use; D011166:Porphyrins / Q000627:therapeutic use; D013673:Technology Assessment, Biomedical; D014481:United States; D014486:United States Food and Drug Administration
D017319:Photosensitizing Agents; D011166:Porphyrins